Concepedia

Publication | Closed Access

Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.

86

Citations

21

References

1998

Year

Irene Virgolini, I Szilvási, Amir Kurtaran, P. Angelberger, Markus Raderer, E. Havlik, F. Vorbeck, Claudia Bischof, M. Leimer, Guido Dorner,
PubMed

Abstract

Indium-111 -DOTA-lanreotide shows a high tumor uptake for a variety of different human tumor types, has a favorable dosimetry over 111In-OCT and is clinically safe.

References

YearCitations

Page 1